dpp-4 inhibitor and glp-1 receptor agonist combination Insights into the Roles of GLP-1, DPP-4, SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology DPP4 Inhibitors vs GLP-1 Agonists

Obesity and Severe Obesity Prevalence in Adults: United States, August 2021August 2023

Barnes shares

& Goke, B

Weekly 1-on-1 coaching Nutrition & coaching app helps track progress Metabolic analysis & hormone support A side-by-side look at two of todays most effective GLP-1 weight loss medications

The growth in the historic period can be attributed to rising prevalence of type 2 diabetes, increased awareness of glycemic control therapies, strong clinical efficacy versus traditional antidiabetics, physician preference for incretin-based therapies, favorable reimbursement in developed markets

Effect of liraglutide treatment on prediabetes and overweight or obesity in Clozapine- or olanzapine-treated patients with schizophrenia spectrum disorder: a randomized clinical trial